IP Library › Assignment 035456/0083
Patent Assignment
Reel/Frame 035456/0083

Change of Name

Recorded: 2015-04-20 Pages: 2
Assignor
INNATE THERAPEUTICS LIMITED
Executed: 2011-08-01
Assignee
INNATE IMMUNOTHERAPEUTICS LIMITED
PO BOX 91806, VICTORIA STREET WEST, AUCKLAND, 1142, NEW ZEALAND
Covered Property (1)
Novel Adjuvant Comprising Non-Toxic Cross-Linked Muramyl Dipeptide (Mdp) Microparticles Derived from Propionibacterium Acnes.
Patent: 8,110,203 →
Application: 11/605,017 →
Publication: US 2007/0154917
Related Assignments (2)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Mar 26, 2007
From: GELDER, FRANK B.
To: VIRIONYX CORPORATION LIMITED
Reel/Frame 019062/0027 →
Change of Name Mar 31, 2011
From: VIRIONYX CORPORATION LIMITED
To: INNATE THERAPEUTICS LIMITED
Reel/Frame 026067/0414 →